IRD
IRD
NASDAQ · Biotechnology

Opus Genetics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$4.06
-0.25 (-5.80%)
As of Nov 14, 2:18 AM ET ·
IRD News2 articles
Opus Genetics Surges 32% on Early Gene Therapy Data; Key Hurdles Ahead
Opus Genetics shares soared 32% on positive early data for its experimental eye gene therapy, but the small, uncontrolled trial leaves many questions before approval.
Analysis
Anthropic's Claude Opus 5.5 Slashes Costs, Amazon's Cloud Demand in Question
Anthropic's Claude Opus 5.5 reduces typical workload costs by 40%, potentially impacting Amazon's cloud capacity usage as AI becomes more efficient.
Technology